A new study has uncovered 15 new breast cancer risk loci.
Genome-scale study points to drivers of tumor evolution and metastasis, provides roadmap for future in vivo Cas9 screens
NIH-supported Roadmap Epigenomics Program have successfully mapped the epigenomes of more than 100 cell types.
New collaboration between Foundation Medicine and H3 aims to develop precision cancer therapies.
23andMe and FDA make significant progress in direct-to-consumer testing.
Anti-cancer cell therapies and the end of the CRISPR-Cas9 controversy.
Tel Aviv University researcher identifies novel genetic mutations through DNA sequencing of afflicted child and family.
A new UK based project, seeks to improve understanding of blood cancer genomics for improved treatment.
UC Berkeley & UC San Francisco launch gene-editing initiative.
Merck join the SGC with multi-million dollar contribution. Merck have announced a contribution of C$7.5 million to the Structural Genomics Consortium (SGC), joining as a member organisation. The supported project focus on per-competitive research to develop small inhibitory molecules called chemical probes to study epigenetic mechanisms of regulation. In collaboration with leading clinical institutions in […]
New epigenetic study offers potential for further stratification in triple negative breast cancer.
House of Commons vote in favour of three-parent-babies in historic debate.
Exciting Startups: GenomeNext
AstraZeneca announces collaborations to use CRISPR technology for genome editing across its drug discovery platform.
Atul Butte leaves Stanford to head up Big Data unit at UCSF.